IVANO Bioscience commercializes biological reagents and analytical kits designed to enhance laboratory performance in developing new vaccines, antiviral drugs, and gene therapies.
We offer safe, functionally validated genetically-modified pseudoviruses at both small and large scales to support preclinical and clinical development needs, ensuring successful laboratory experiments.
We are also developing the next generation of neutralizing detection assays with a patent-pending kit that delivers results 10 times faster than competitors, enabling high-throughput screening in standard laboratory settings.